
AVXL P/E Ratio
P/E Ratio as of Jul 2, 2025: -19.01
Average-15.78
Median-16.05
Minimum-19.01
Maximum-13.89
-19.01
Past Month-5.41 (39.78%)
The P/E ratio for AVXL is -19.01 as of Jul 2, 2025. This represents a increase of 23.84% compared to its 12-month average P/E ratio of -15.35. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Anavex Life Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anavex Life Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anavex Life Sciences to industry peers.
Anavex Life Sciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Anavex Life Sciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Anavex Life Sciences to industry peers.
AVXL P/E Ratio Insights
See Anavex Life Sciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AVXL
Order type
Buy in
Order amount
Est. shares
0 shares
AVXL P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $9.33 | -16.78 |
Jun 2, 2025 | $7.56 | -13.60 |
May 1, 2025 | $9.31 | -16.86 |
Apr 1, 2025 | $8.02 | -14.52 |
Mar 3, 2025 | $8.27 | -14.98 |
Feb 3, 2025 | $8.64 | -16.79 |
Jan 2, 2025 | $12.15 | -23.62 |
AVXL End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -19.01 | -8.91% |
2024 | -20.87 | +33.87% |
2023 | -15.59 | +5.12% |
2022 | -14.83 | -52.05% |
2021 | -30.93 | +159.92% |
2020 | -11.90 | — |
FAQs About Anavex Life Sciences (AVXL) P/E ratio
The latest P/E ratio of AVXL is -19.01, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Anavex Life Sciences’s last 12-month average P/E ratio is -15.35, compared to its current P/E ratio of -19.01. This reflects a increase of 23.84%.
Anavex Life Sciences’s current P/E ratio of -19.01 is higher than its last 12-month average P/E of -15.35. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Anavex Life Sciences’s average P/E ratio over the last 3 years is -13.58. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Anavex Life Sciences’s average P/E ratio over the last 5 years is -17.65. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.